Skip to main content

Table 2 Study Time Points

From: Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial

Process, Outcome or Test Time Point
Recruitment Pre-Intervention Intervention Post-Intervention Follow-Up
Lab Visit Week (Total = 12) Lab Visit Month
#1 #2 3 6 9 #3 #4 6 12
Informed Consent   ×a         
PAR-Q+   ×a         
ECG   ×a         
Blood Pressure   ×a      ×    
Resting HR   ×a      ×    
Participant Information   ×         
FACIT-F ×   × × × ×   × × ×
ERAS-r    × × × ×   × × ×
FACT-G    ×      ×   
CES-D   ×    ×   × ×   
BPI-sf   ×    ×   ×    
SPS   ×      ×    
GLTEQ   ×      ×   × ×
ISI   ×      ×    
Venous Blood Sample   ×      ×    
Body Mass   × ×     × ×   
Stature   ×      ×    
Neuromuscular Familiarization   ×         
Start of 15-day Actigraphy   ×       ×   
Sleep Diary   ×       ×   
HRV    ×      ×   
Maximal Exercise Test   ×      ×    
DXA    ×      ×   
CSA    ×      ×   
Grip Strength    ×      ×   
Neuromuscular Function    ×      ×   
Intermittent Cycling Test    ×      ×   
  1. aIndicates that the item is part of the screening process. BPI-sf, Brief Pain Inventory Short Form, CES-D, Center for Epidemiological Studies on Depression Scale; CSA, cross-sectional area; DXA, dual-energy X-ray absorptiometry; ECG, electrocardiogram; ESAS-r, Edmonton Symptom Assessment System (revised version); FACIT-F, Functional Assessment of Chronic Illness Therapy Fatigue Scale; Functional Assessment of Cancer Therapy - General (FACT-G); GLTEQ, Godin Leisure-Time Exercise Questionnaire; HR, heart rate; HRV, heart rate variability; ISI, insomnia severity index; PAR-Q+, Physical Activity Readiness Questionnaire for Everyone; SPS, Social Provision Scale